Skip to content
lifestyle.tweeternet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
InflaRx N.V.
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 6, 2026
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
May 4, 2026
InflaRx to Report First Quarter 2026 Results on May 7, 2026
May 1, 2026
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 28, 2026
←
Previous Page
1
2